Cargando…
Direct-Acting Oral Anticoagulants: A Resident-Based Workshop to Improve Knowledge and Confidence
INTRODUCTION: Direct-acting oral anticoagulant (DOAC) prescriptions have increased steadily since the first, dabigatran, was Food and Drug Administration-approved in 2010. They have multiple advantages over vitamin K antagonists including fixed dosing without coagulation lab monitoring, rapid onset...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Association of American Medical Colleges
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526504/ https://www.ncbi.nlm.nih.gov/pubmed/33015358 http://dx.doi.org/10.15766/mep_2374-8265.10981 |